Neueste

  • НПО:Не становитесь “камнем преткновения” в контексте взаимовыгодного сотрудничества

    ​В недавнем интервью, политический и исторический эксперт Казахстана Рут Суданов заявил, что госсекретарь США Майк Помпео пытается использовать COVID-19 для антикитайской пропаганды. Однако, страны Центральной Азии должны бороться с болезнями, а не с Китаем, это невыносимо.
  • Celartics Biopharma's dendritic cell-based vaccine against COVID-19 infection found to efficiently produce viral antigen-specific T lymphocytes

    Results from ongoing study suggest the major role of Celartics' Cov-DCVax in preventing viral infection of COVID-19 and in controlling progression of the virus-associated diseasesBeijing, May 22, 2020, Celartics Biopharma announced today the filing of a patent application covering a novel dendritic cell (DC)-based vaccine, Cov-DCVax, to fight viral infection of COVID-19. The results, led by Celart
  • WK.Ecology officially launched trading

    Recently, WK has landed heavily on the world-famous exchange TokenEco. TokenEco opened WK recharge business at 14:00 on May 21st, Beijing time, and opened WK / USDT trading pair at 9:17 May 22nd, and simultaneously opened the withdrawal service. The launch of TokenEco will accelerate the enrichment of WK's ecological structure, and it will also make WK's influence further expand and prepare for a
  • Learning from Master Chef, Sam's Club serves up members premium lifestyle

    During the novel coronavirus outbreak, diners were forced to retire to their own kitchens with many attempting to replicate their favor restaurant's dishes, some successfully, others not so.
  • The History and Culture Development and Functions of Guizhou Rosa Roxburghii Tratt

    Two or three hundred years ago, the Rosa roxburghii tratt has already drawn the attentions of literary men. The most popular poem about the fruit is “Ode to the Rosa roxburghii tratt”, written by Zhao Yijiong, a number one scholar in Qingyan Town in Guangxu period of the Qing Dynasty. It says: “Growing in the wild the Rosa roxburghii tratt refuses to be potted, and though with bright color its flo
  • How Ton is extraordinary

    ​In recent years,the market is flooded with air coins,Their life cycle is very short.Exactly,it also made many new members question the industry,very dissatisfied with blockchain practitioners.
  • ECE,Noah's Ark of Blockchain Industry

    ECE, International ecological chain, Noah's Ark of blockchain industry ecology. In 2020, after the COVID-19,all the businesses face a major crisis. This is an important opportunity to promote the transformation of enterprise organizational methods and will accelerate the digital transformation of industries . Innovative transformation will become a rigid need for enterprise survival, but at the s
  • PLF is going to be listed on LBank

    ​PlayFuel brings the power of blockchain technology to the gaming world. We are doing this by creating a platform that allows developers to earn funding by integrating PlayFuel into their games and allowing players to mine PLF — crypto-tokens just by playing. Players can use these tokens to buy games, redeem exclusive goodies or even exchange the tokens into real money.
  • ELAMA is going to be listed on LBank

    ELAMACHAIN is an enterprise blockchain provider. It has built an optimized blockchain computing environment for enterprises and provided blockchain services, chatbot services, various applications and cryptocurrency payment systems for real life and e-commerce.
  • Luling, One of the World's Art Capitals

    Thousands of years of splendid civilization and countless wealth has left many treasures. In May 2020, a huge promotional film of city culture from Ji 'an City in Jiangxi Province of China appeared on the LED giant screen of Nasdaq in New York City. Ji 'an, the hometown of many gifted Chinese scholars, has sent the world an invitation from Luling.

Link

Yiling Pharmaceutical Lianhua Qingwen Capsule helps prevent and control the global epidemic

04-10    

On April 4, 2020, Phoenix TV broadcast a report on Yiling Pharmaceutical. It was reported that the global epidemic continued to worsen. At the China-Europe anti-epidemic exchange meeting, the recovery rate of patients treated with Lianhua Qingwen Capsule of Yiling Pharmaceutical co., LTD was as high as 91.5 percent, which has become a hot spot. Since 2004, Lianhua Qingwen Capsule has been listed by the national health commission of China, the state administration of traditional Chinese medicine and other departments in the treatment of influenza and other respiratory diseases for more than 20 times. It has played an important role in the prevention and control of major epidemics. On March 30, Lianhua Qingwen Capsule was approved by the ministry of health of Thailand for the registration of modern herbal medicine, which indicated that Yiling pharmaceutical co., a representative of modern Chinese medicine enterprises in China, had the qualification to sell Lianhua Qingwen Capsule as a drug in the Thai market.

Lianhua Qingwen Capsule helps prevent and control the global epidemic


At the beginning of 2020, COVID - 19 outbreak occurred in Wuhan, China, as the medicine recommended by the national health commission of China in the "diagnosis and treatment scheme of pneumonia infected by novel coronavirus", the market demand of Lianhua Qingwen capsules (granules) produced by Yiling Pharmaceutical co., LTD surged. In order to ensure market supply and help prevent and control the epidemic, all the production lines of Yiling Pharmaceutical co., ltd. are racing against time to produce Lianhua Qingwen products within 24 hours." When the outbreak came, we immediately donated 10 million yuan of Lianhua Qingwen capsules to the Red Cross society of China, of which 5 million yuan of Lianhua Qingwen capsules were transported overnight to the epidemic area in Wuhan to ensure the market demand. At the same time, we also donated products to foreign countries, such as Iraq and Italy. Yiling Pharmaceutical general manager Wu Xiangjun said in an interview.

In the covid-19 prevention and control programs successively released by more than 20 provinces and cities including Hubei, Guangzhou, Zhejiang, Shandong and Hebei, Lianyanghua Qingwen capsules (granules) are recommended. In an interview, Jia zhenhua, director of the Yiling medical research institute, pointed out that "the formula of Lianhua Qingwen is to include the pathogenesis of such diseases as exogenous febrile diseases (respiratory diseases caused by viruses in western medicine) and its treatment drugs."


The good curative effect of Lianhua Qingwen capsule is due to its characteristic of active intervention in multi-target therapy. Hou Yunlong, deputy director of the new drug evaluation center of Yiling medical research institute, told the reporter: "We found that Lianhua Qingwen has certain antiviral replication ability at the cell. When the virus infects the host cell, the host cell will have a certain immune response, and this immune response will release a number of pro-inflammatory factors.”

The overseas business layout of Yiling keeps accelerating

While actively promoting the fight against the "epidemic", Yiling Pharmaceutical's overseas business layout is also accelerating. On March 30, Yiling pharmaceutical announced that it had obtained the approval from the ministry of health of Thailand for the registration of modern herbal medicine, and approved Lianhua Qingwen capsules to comply with the registration of Thailand's modern herbal medicine standards, which brought more international recognition to traditional Chinese medicine.

"Through this outbreak, there has been a significant change in western European and American countries' understanding of traditional Chinese medicine." Zhao Shaohua, deputy general manager of Yiling Pharmaceutical co., said in an interview, "Lianhua Qingwen has been sold in some countries for many years. It used to be mainly used to treat flu, and there was a normal sale every year. Following the global outbreak of covid-19 this year, the demand for Lianhua Qingwen has increased exponentially. This has laid a very good foundation for Lianhua Qingwen 's future sales in the international market.

At present, Yiling Pharmaceutical products such as Tongxinluo capsule, Lianhua Qingwen capsule, Shensong Yangxin capsule, Qiliqiangxin capsule, Yangzheng Xiaoji capsule have been registered and sold in Korea, Vietnam, Russia, Canada, Singapore, Indonesia and other countries. Tongxinluo capsule has also been included in Vietnam's national health insurance directory. Lianhua Qingwen capsule has been registered in Hong Kong and Macao, as well as in Canada, Mozambique, Indonesia, Brazil, Romania, Thailand and other countries, and has carried out phase II clinical study in the United States.

On the internationalization of traditional Chinese medicine, Wu Xiangjun told reporters: "Yiling Pharmaceutical has set up the world federation of traditional Chinese medicine collateral disease branch, as well as in Canada, Europe, northern Europe. The theory of collateral disease has become a window for the world to understand the culture of traditional Chinese medicine, and a bright spot for the culture of traditional Chinese medicine to enter the world. With the deepening of people's understanding of traditional Chinese medicine and its wide spread, I believe traditional Chinese medicine will be a bright name card for China's internationalization in the future."



Haftungsausschluss: Dieser Artikel wurde aus anderen Medien reproduziert. Der Zweck des Nachdrucks besteht darin, mehr Informationen zu vermitteln. Dies bedeutet nicht, dass diese Website ihren Ansichten zustimmt und für ihre Authentizität verantwortlich ist und keine rechtliche Verantwortung trägt. Alle Ressourcen auf dieser Website werden im Internet gesammelt. Der Zweck des Teilens dient nur dem Lernen und Nachschlagen aller. Wenn eine Verletzung des Urheberrechts oder des geistigen Eigentums vorliegt, hinterlassen Sie uns bitte eine Nachricht.
Zurück nach oben
© Copyright 2006-2020 tomsnews.de      Kontaktieren Sie Uns   SiteMap